News
-
-
PRESS RELEASE
Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Evotec SE announces strong progress in strategic partnership with Bristol Myers Squibb for molecular glue degraders, triggering payments of US$75m. Joint pipeline expanding in oncology field -
-
-
-
-
-
-
-